Buparvaquone
Therapeutic Category:
Antiprotozoal
Inhibits mitochondrial electron transport at cytochrome bc1 complex of protozoa
Primary Use:
Treatment of bovine theileriosis (Theileria annulata, T. parva)
Specifically targets Theileria species (T. annulata, T. parva)
Target Species:
Field animals, Milking animals
Status:
Commercial
Monograph:
In House
Regulatory Status:
DMF
Disclaimer*
NGL FINE CHEM LIMITED is committed to protect the intellectual property (IP) generated in house and equally committed to respect the IP rights of all entities. Certain pipeline products may have valid patent(s) by other in India and/or in other jurisdictions. NGL offers such patented products for research and testing purpose only. The buyer will have the exclusive responsibility to respect the third party patent rights whether related to product or process.